The kick-off of the new Pan-European vaccine network was held on 5 March 2021. The network serves as a single entry-point for all stakeholders in COVID-19 vaccine development for phase 2 & 3 trials in Europe.
for articles/videos/studies
Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.
Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.
